Becton, Dickinson and Company Common Stock (BDX) stock analysis

BDX · Becton, Dickinson and Company Common Stock

Latest recorded price: USD 216.48

Model-estimated fair value: USD 171.86. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Medical Instruments & Supplies

At $216.48, BDX trades 26.0% above the model's base-case value of $171.86. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $128.36 in the conservative case and $220.85 in the optimistic case, with a valuation confidence score of 69/100. About 80% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 5.0%, ROIC 4.9%. The model flags 1 risk signal for this company.

Similar companies in Healthcare